British American Tobacco finalizes Russia exit with sale to local managers

British American Tobacco finalizes Russia exit with sale to local managers


British American Tobacco has finalized its exit from Russia about 18 months after it pledged to do so in the wake of Moscow’s invasion of Ukraine.

The multinational cigarette maker said in a statement Thursday it agreed “to sell its Russian and Belarusian businesses in compliance with local and international laws.”

Financial terms of the deal were not disclosed, but the transaction is expected to be completed within a month, the company said.

“Upon completion, BAT will no longer have a presence in Russia or Belarus and will receive no financial gain from ongoing sales in these markets,” it added.

Since Russia invaded Ukraine in early 2022, thousands of companies such as Apple, McDonald’s and Coca-Cola pulled out of Russia. However, other global tobacco giants are still doing business in the country, including Japan Tobacco International and Philip Morris International.

London-based BAT is a key player in the global tobacco market with business operations in over a hundred countries, and top brands including Camel and Newport.

It controlled nearly 25% of the Russia’s tobacco market, which is the fourth-largest in the world, according to Reuters.

The buyer is a consortium led by members of BAT Russia’s management team, which will wholly own the Russian and Belarusian businesses, BAT said. They will then be known as the ITMS Group.

BAT said the employment of workers in Russia will remain comparable to their existing terms for at least two years after the deal closes.



Source

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
Health

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street’s expectations for the second quarter as it works to cut costs. […]

Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
Health

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]

Read More
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Health

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s […]

Read More